This is a non-core endpoint: only basic statistics are computed.
See these related core endpoints for full statistics:
Other problems related to upbringing
Z21_OTHER_PROBL_RELATED_UPBRI
No definition available.
Endpoint definition
↥Report an error or suggest an improvement for this endpoint codes
Endpoint definition steps |
FinnGen |
|---|---|
Phenotype data |
557745 |
1. Apply sex-specific ruleNone |
557745 |
2. Check conditionsNone |
557745 |
3. Check pre-conditions, main-only, mode, registry filtersRegistry filters: 2 out of 7 registries used, show all original rules. |
195 |
4. Check minimum number of eventsNone |
195 |
5. Include endpointsNone |
195 |
6. Filter based on genotype QC (FinnGen only) |
164 |
Control definitions (FinnGen only)
Extra metadata
- Level in the ICD hierarchy
- 3
- First used in FinnGen datafreeze
- DF4
- Parent code in ICD-10
- Z5[5-9]|Z6
Similar endpoints
↥List of similar endpoints to
Other problems related to upbringing
based on the number of shared cases.
Similar with more cases:
- Persons with potential health hazards related to socioeconomic and psychosocial circumstances
- Factors influencing health status and contact with health services
- Any prescribed medicine buy
- Any event in hilmo or specialist outpatient
Similar with less cases:
None
Case counts by codes
↥
Summary Statistics
↥-FinRegistry-
This endpoint is excluded from FinRegistry analyses (omitted endpoint).
-FinnGen-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 164 | 123 | 41 |
| Unadjusted period prevalence (%) | 0.04 | 0.04 | 0.02 |
| Median age at first event (years) | 14.75 | 15.03 | 13.89 |
-FinnGen-
Age distribution of first events
-FinnGen-
Year distribution of first events
-FinnGen-
Cumulative Incidence Function
Not a core endpoint, no data to show.
CodeWAS
↥CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.
This is a new tool, please reach out using the contact form for feedback and improvement ideas.
First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.
Matched cohort
- Matched cases
- 186
- Matched controls
- 1860
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
Z62.8
ICD-10 Finland
Other specified problems related to upbringing
+∞
58.5
53
*
Z62.2
ICD-10 Finland
Institutional upbringing
+∞
51.5
47
*
F93.89
ICD-10 Finland
Other childhood emotional disorders
21.7
46.7
37
21
Z00.4
ICD-10 Finland
General psychiatric examination, not elsewhere classified
8.0
45.7
100
236
T36
ICD-10 Finland
Poisoning by systemic antibiotics
14.5
43.9
44
39
N05AH04
ATC
quetiapine; oral
6.7
38.0
98
264
F60.30
ICD-10 Finland
Emotionally unstable personality disorder, impulsive
14.6
35.1
34
28
Z62.0
ICD-10 Finland
Inadequate parental supervision and control
+∞
33.3
31
*
X69
ICD-10 Finland
Intentional self-poisoning by and exposure to other and unspecified chemicals and noxious substances
12.7
30.4
32
30
112
Kela drug reimbursment
Severe psychotic and other severe mental disorders
8.9
29.7
42
59
F32.9
ICD-10 Finland
Depressive episode, unspecified
5.1
25.9
80
240
Z62.9
ICD-10 Finland
Problem related to upbringing, unspecified
+∞
25.6
24
*
N05AX08
ATC
risperidone; systemic
7.3
25.3
43
74
N06AX11
ATC
mirtazapine; oral
4.6
23.8
95
344
N03AX09
ATC
lamotrigine; oral
6.9
22.7
40
71
N05AH03
ATC
olanzapine; systemic
6.5
22.3
42
80
N05AX12
ATC
aripiprazole; systemic
6.2
20.4
40
79
F29
ICD-10 Finland
Unspecified nonorganic psychosis
6.7
20.3
36
64
Z61.8
ICD-10 Finland
Other negative life events in childhood
+∞
20.2
19
*
IAA01
NOMESCO Finland
Assessment of need for psychiatric treatment
6.3
18.6
35
66
F92.8
ICD-10 Finland
Other mixed disorders of conduct and emotions
105.2
17.9
19
*
N05BA04
ATC
oxazepam; oral
3.8
17.0
73
268
Z62.4
ICD-10 Finland
Emotional neglect of child
+∞
16.9
16
*
Z63.7
ICD-10 Finland
Other stressful life events affecting family and household
44.4
16.7
20
5
ICB01
NOMESCO Finland
Psychiatric treatment plan, standard
5.6
15.6
33
69
N06AB03
ATC
fluoxetine; oral
4.7
15.5
42
109
F32.2
ICD-10 Finland
Severe depressive episode without psychotic symptoms
4.7
15.4
41
105
F92.0
ICD-10 Finland
Depressive conduct disorder
49.5
15.4
18
*
N06AB04
ATC
citalopram; systemic
4.4
15.1
45
126
F92.9
ICD-10 Finland
Mixed disorder of conduct and emotions, unspecified
39.6
14.7
18
5
F33.2
ICD-10 Finland
Recurrent depressive disorder, current episode severe without psychotic symptoms
5.8
14.6
29
57
F33.9
ICD-10 Finland
Recurrent depressive disorder, unspecified
5.4
14.6
32
69
F32.10
ICD-10 Finland
Moderate depressive episode without somatic syndrome
3.9
14.3
53
173
N05CF01
ATC
zopiclone; oral
3.9
14.2
51
163
ZY010
NOMESCO Finland
Hospital outpatient
4.8
14.0
36
89
F43.22
ICD-10 Finland
Adaptation disorder with mixed anxiety and depression
5.5
13.8
29
60
X44
ICD-10 Finland
Accidental poisoning by and exposure to other and unspecified drugs, medicaments and biological substances
18.0
13.8
21
13
Z63.2
ICD-10 Finland
Inadequate family support
+∞
13.7
13
*
IGY99
NOMESCO Finland
Other psychiatric treatment contact
5.6
13.6
28
57
N06AX12
ATC
bupropion; oral
4.1
13.0
41
119
Z2445
NOMESCO Finland
Psychologist
4.6
13.0
35
90
F93.9
ICD-10 Finland
Childhood emotional disorder, unspecified
75.1
12.8
14
*
F41.9
ICD-10 Finland
Anxiety disorder, unspecified
3.2
12.7
71
300
N06AB06
ATC
sertraline; oral
3.5
12.6
56
205
A06AC01
ATC
ispaghula (psylla seeds); oral
3.7
12.5
47
154
F60.3
ICD-10 Finland
Emotionally unstable personality disorder
17.5
12.4
19
12
N05AF03
ATC
chlorprothixene; systemic
19.7
12.3
18
10
Z3231
NOMESCO Finland
Registered nurse
3.0
11.4
69
302
N05AH02
ATC
clozapine; systemic
12.3
11.4
20
18
C07AB07
ATC
bisoprolol; oral
3.4
11.3
50
182
F41.2
ICD-10 Finland
Mixed anxiety and depressive disorder
3.1
11.2
66
284
ICZ03
NOMESCO Finland
Participation in compiling a psychiatric treatment plan
4.6
10.9
28
69
F39
ICD-10 Finland
Unspecified mood [affective] disorder
5.9
10.7
20
37
N06AX16
ATC
venlafaxine; oral
3.5
10.6
44
153
Z63.8
ICD-10 Finland
Other specified problems related to primary support group
116.3
10.5
11
*
Z10.1
ICD-10 Finland
Routine general health check-up of inhabitants of institutions
116.3
10.5
11
*
P99
ICPC
Psychological disorders other
5.1
10.3
23
50
N05AA02
ATC
levomepromazine; systemic
10.0
10.3
20
22
N03AX16
ATC
[U] pregabalin
3.9
10.3
34
101
P29
ICPC
Psychological sympt/compl other
3.1
10.3
53
210
C07AA05
ATC
propranolol; systemic
2.9
10.1
63
278
N03AG01
ATC
valproic acid; systemic, rectal
5.0
10.1
23
51
F43.1
ICD-10 Finland
Post-traumatic stress disorder
4.2
10.1
29
78
N05BA01
ATC
diazepam; systemic, rectal
4.2
10.1
29
78
N06AB10
ATC
escitalopram; oral
2.8
10.0
71
335
Z2446
NOMESCO Finland
Social worker
3.9
10.0
33
98
F10.1
ICD-10 Finland
Mental and behavioural disorders due to use of alcohol, Harmful use
7.6
9.7
22
32
IGY02
NOMESCO Finland
Psychiatric monitoring contact
4.1
9.5
29
81
IGV01
NOMESCO Finland
Psychiatric network contact
10.4
9.5
18
19
J01MA02
ATC
ciprofloxacin; systemic
2.9
9.5
59
259
IAB08
NOMESCO Finland
Consultation concerning a patient who has attempted suicide
+∞
9.5
9
*
Z63.5
ICD-10 Finland
Disruption of family by separation and divorce
+∞
9.5
9
*
J20.9
ICD-10 Finland
Acute bronchitis, unspecified
3.1
9.4
47
182
N05BE01
ATC
buspirone; oral
13.5
9.0
15
12
IGY01
NOMESCO Finland
Accelerated psychiatric treatment contact
4.5
9.0
23
56
R10.3
ICD-10 Finland
Pain localized to other parts of lower abdomen
2.6
9.0
81
427
UJD10
NOMESCO Finland
Esophagoscopy, gastroscopy and duodenoscopy
3.2
8.8
40
146
IEY05
NOMESCO Finland
Dedicated profession-specific psychiatric intervention, individual
3.9
8.8
28
81
F91.3
ICD-10 Finland
Oppositional defiant disorder
52.5
8.8
10
*
X58
ICD-10 Finland
Exposure to other specified factors
2.9
8.5
50
211
N02AX02
ATC
tramadol; systemic, rectal
2.7
8.5
58
265
F94.1
ICD-10 Finland
Reactive attachment disorder of childhood
+∞
8.4
8
*
F60.31
ICD-10 Finland
Emotionally unstable personality disorder, borderline condition
9.6
8.2
16
18
X59
ICD-10 Finland
Exposure to unspecified factor
2.8
8.2
52
229
A06AD11
ATC
lactulose; oral
4.2
8.0
22
57
R51.80
ICD-10 Finland
Headache
2.6
7.9
61
295
P72
ICPC
Schizophrenia
11.5
7.9
14
13
SPAT1240
SPAT
Therapeutic discussion
2.8
7.9
50
219
ZXE13
NOMESCO Finland
Procedure duration 90 to 119 minutes
4.0
7.9
24
67
IBZ01
NOMESCO Finland
Profession-specific psychiatric evaluation
4.4
7.6
20
50
N10
ICD-10 Finland
Acute tubulo-interstitial nephritis
3.2
7.5
32
112
IFA99
NOMESCO Finland
Other psychiatric pharmacotherapy service
11.5
7.4
13
12
Z30.2
ICD-10 Finland
Sterilization
4.6
7.4
18
42
R10.4
ICD-10 Finland
Other and unspecified abdominal pain
2.3
7.4
97
594
Z62.1
ICD-10 Finland
Parental overprotection
+∞
7.3
7
*
F33.10
ICD-10 Finland
Recurrent depression, moderate episode without somatic syndrome
3.5
7.3
27
86
IFA01
NOMESCO Finland
Psychiatric pharmacotherapy plan, not specified
7.1
7.3
17
26
A02BC02
ATC
pantoprazole; systemic
2.3
7.2
97
597
Z2221
NOMESCO Finland
Medical doctor
2.5
7.1
60
301
F31.9
ICD-10 Finland
Bipolar affective disorder, unspecified
6.3
7.1
18
31
F32.3
ICD-10 Finland
Severe depressive episode with psychotic symptoms
8.1
7.1
15
20
X78
ICD-10 Finland
Intentional self-harm by sharp object
14.5
7.0
11
8
P19
ICPC
Drug abuse
14.5
7.0
11
8
F32.8
ICD-10 Finland
Other depressive episodes
8.8
7.0
14
17
F31.7
ICD-10 Finland
Bipolar affective disorder, currently in remission
8.8
7.0
14
17
E66.8
ICD-10 Finland
Other obesity
4.2
6.9
19
49
AA1AD
NOMESCO Finland
CT of head and brain
3.0
6.9
34
130
P74
ICPC
Anxiety disorder/anxiety state
3.0
6.8
33
125
F83
ICD-10 Finland
Mixed specific developmental disorders
8.3
6.7
14
18
Z72.8
ICD-10 Finland
Other problems related to lifestyle
23.5
6.7
9
*
F33.30
ICD-10 Finland
Recurrent depression, severe episode without somatic syndrome
23.5
6.7
9
*
F91.9
ICD-10 Finland
Conduct disorder, unspecified
23.5
6.7
9
*
SPAT1309
SPAT
Guidance related to psychoactive substances / risk behaviour
4.5
6.7
17
41
F31.6
ICD-10 Finland
Bipolar affective disorder, current episode mixed
10.6
6.6
12
12
Z29
ICPC
Social problem NOS
6.1
6.6
17
30
F90.0
ICD-10 Finland
Disturbance of activity and attention
2.7
6.6
40
170
ICB03
NOMESCO Finland
Psychiatric treatment plan, monitoring
6.6
6.6
16
26
S18
ICPC
Laceration/cut
2.2
6.6
83
493
P01AB01
ATC
metronidazole; oral, rectal
2.3
6.6
72
404
W14
ICPC
Contraception female other
2.5
6.5
47
219
Z03.9
ICD-10 Finland
Observation for suspected disease or condition, unspecified
2.5
6.5
47
219
F60.9
ICD-10 Finland
Personality disorder, unspecified
15.0
6.5
10
7
IEV99
NOMESCO Finland
Other psychiatric network intervention
9.8
6.4
12
13
K59.0
ICD-10 Finland
Constipation
5.4
6.4
18
36
M54.5
ICD-10 Finland
Low back pain
2.2
6.3
80
474
P18
ICPC
Medication abuse
18.8
6.3
9
5
Z72.2
ICD-10 Finland
Drug use
18.8
6.3
9
5
Z63.4
ICD-10 Finland
Disappearance and death of family member
18.8
6.3
9
5
F33.1
ICD-10 Finland
Recurrent depressive disorder, current episode moderate
4.3
6.3
17
43
WYA30
NOMESCO Finland
Treatment of a patient needing special arrangements
3.0
6.3
31
118
Z61.2
ICD-10 Finland
Altered pattern of family relationships in childhood
+∞
6.3
6
*
Z61.5
ICD-10 Finland
Problems related to alleged sexual abuse of child by person outside primary support group
+∞
6.3
6
*
F84.8
ICD-10 Finland
Other pervasive developmental disorders
27.7
6.3
8
*
Z76.9
ICD-10 Finland
Person encountering health services in unspecified circumstances
3.0
6.2
30
113
K59.09
ICD-10 Finland
Constipation, unspecified
5.6
6.2
17
33
R4160
NOMESCO Finland
Other therapy enhancing rehabilitation
5.6
6.2
17
33
GD1AA
NOMESCO Finland
Thorax X-ray examination
2.3
6.2
59
311
N06BA04
ATC
methylphenidate; oral
2.8
6.2
35
144
Z76.0
ICD-10 Finland
Issue of repeat prescription
2.2
6.2
67
373
GD1QA
NOMESCO Finland
Supine thorax X-ray examination
6.4
6.1
15
25
N05CD07
ATC
temazepam; oral
10.5
6.1
11
11
R11
ICD-10 Finland
Nausea and vomiting
2.9
6.1
32
126
NH1AA
NOMESCO Finland
Ankle X-ray examination without contrast
3.5
6.1
22
69
Z03.89
ICD-10 Finland
Observation for other suspected diseases and conditions
2.5
6.1
42
191
N06AX21
ATC
duloxetine; oral
3.1
6.0
27
97
LabWAS
↥OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
cases
controls
unit
-log10(p)
N cases
N controls
116
592
3.55
15.86
4.6
4.7
8.39
9.99
umol/l
2.71
109
554
91
434
3.15
13.30
3.8
3.0
—
—
—
0
0
149
960
3.78
12.73
7.8
5.7
79.14
76.68
u/l
0.27
142
903
31
81
4.39
11.19
3.0
9.4
1.53
1.22
mmol/l
0.83
31
76
88
454
2.78
10.57
6.1
6.6
1.22
1.22
mmol/l
0.06
83
425
76
367
2.81
10.32
3.8
2.7
0.20
0.15
e6/l
0.33
57
258
61
263
2.96
10.21
2.3
1.5
1.55
1.39
%
2.39
55
243
18
17
11.59
10.03
41.4
23.2
1368.33
1250.24
nmol/l
0.19
18
17
54
220
3.05
9.97
3.0
2.6
7.35
3.87
e6/l
1.03
28
94
77
383
2.72
9.78
4.5
2.5
49.97
56.77
u/l
1.70
70
357
53
226
2.88
8.92
3.2
2.5
0.58
0.52
e6/l
0.11
26
100
132
883
2.70
8.79
19.6
7.9
4.59
3.90
e9/l
2.22
115
760
31
99
3.56
8.41
4.6
8.9
106.03
105.20
mmol/l
0.45
31
99
165
1286
3.51
7.47
6.1
4.4
14.60
14.34
pmol/l
0.64
158
1193
31
107
3.28
7.43
1.5
1.5
0.17
0.27
mg/l
0.56
13
46
37
143
2.98
7.34
2.9
2.1
31.15
29.76
u/l
0.13
26
117
88
520
2.31
7.23
6.1
6.4
1.22
1.22
mmol/l
0.18
76
451
18
44
4.42
6.99
3.6
5.9
0.56
0.58
%
0.08
18
44
83
486
2.28
6.89
1.8
1.6
97.71
94.51
pmol/l
0.30
48
270
107
705
2.22
6.55
2.9
2.3
—
—
—
0
0
28
98
3.19
6.54
2.4
4.6
23.84
24.05
mmol/l
0.21
28
98
144
1077
2.49
6.46
4.4
2.8
33.07
28.90
u/l
0.72
137
1040
111
750
2.19
6.29
3.2
2.5
—
—
—
0
0
32
127
2.84
6.01
1.5
1.5
1050.37
1072.06
nmol/l
0.05
27
106
11
12
9.66
5.87
1.8
1.3
—
—
—
0
0
161
1291
2.84
5.86
5.1
2.7
5.67
5.39
mmol/l
1.85
153
1193
112
775
2.12
5.78
5.7
5.1
6.17
6.04
mmol/l
0.31
104
659
99
664
2.05
5.44
2.9
2.5
61.60
67.72
nmol/l
1.86
92
621
120
876
2.04
5.08
3.8
3.2
0.00
0.00
estimate
-0.00
30
208
14
29
5.13
4.92
4.5
3.2
57.17
51.33
%
0.29
14
29
120
883
2.01
4.88
3.9
3.3
0.00
0.00
estimate
-0.00
33
207
118
871
1.97
4.66
3.9
3.2
0.00
0.00
estimate
-0.00
31
214
17
54
3.36
4.61
1.5
1.3
—
—
—
0
0
159
1321
2.40
4.42
13.8
7.5
107.98
105.87
ml/min/173m2
0.70
148
1116
14
41
3.61
4.27
4.6
13.1
93.11
93.97
%
0.26
14
41
60
363
1.96
4.19
3.2
2.4
2.36
2.36
mmol/l
0.19
54
337
94
662
1.85
4.10
3.5
3.0
0.00
0.01
estimate
0.80
27
182
7
7
10.33
4.04
1.9
3.9
12.90
19.36
umol/l
—
7
7
16
55
3.09
3.84
1.7
1.5
—
—
—
0
0
140
1132
1.96
3.81
5.2
3.4
35.85
35.65
mmol/mol
0.11
133
1076
15
50
3.18
3.78
1.7
1.1
—
—
—
0
0
54
328
1.91
3.67
2.3
2.1
25.42
17.62
ng/l
0.23
18
114
15
51
3.11
3.67
1.7
1.1
—
—
—
0
0
63
403
1.85
3.65
4.8
2.9
1.02
1.02
kg/l
0.13
45
248
53
325
1.88
3.49
1.6
1.3
19.54
19.08
nmol/l
0.07
47
296
20
84
2.55
3.36
9.8
3.9
—
—
—
0
0
13
39
3.51
3.30
3.6
13.7
2.53
1.15
%
1.72
13
39
24
111
2.33
3.30
1.9
1.4
—
—
—
0
0
10
24
4.34
3.24
1.4
1.1
—
—
—
0
0
8
15
5.52
3.22
3.3
1.7
17.58
17.63
%
—
8
15
69
469
1.75
3.21
3.9
3.2
0.00
0.00
estimate
0.50
30
207
12
36
3.49
3.08
3.8
14.6
0.55
0.66
%
0.43
12
36
82
597
1.67
2.91
1.5
1.5
0.51
3.00
u/ml
1.62
29
149
21
98
2.29
2.83
3.4
7.2
24.39
25.42
mmol/l
0.95
21
98
26
133
2.11
2.82
2.0
1.5
—
—
—
0
0
154
1335
1.89
2.76
4.4
3.1
2.68
2.72
mmol/l
0.28
144
1281
28
151
2.01
2.65
1.5
1.4
225.51
288.85
miu/ml
0.35
11
83
174
1585
2.52
2.58
17.3
9.7
18.32
20.55
mg/l
0.54
156
1236
5
7
7.30
2.56
2.0
1.6
1.22
1.20
mmol/l
—
5
7
29
161
1.95
2.53
1.7
2.8
3.94
8.69
umol/l
1.06
24
131
25
133
2.02
2.46
2.0
1.5
—
—
—
0
0
32
186
1.87
2.44
4.1
5.2
56.58
14.46
mg/mmol
0.36
18
139
16
71
2.37
2.42
2.1
1.7
—
—
—
0
0
32
187
1.86
2.40
1.8
1.7
—
—
—
0
0
11
39
2.93
2.39
1.3
1.1
3.40
3.50
mmol/l
0.24
11
39
11
39
2.93
2.39
1.0
1.2
—
—
—
0
0
152
1332
1.77
2.37
4.0
2.9
1.34
1.44
mmol/l
2.17
142
1281
152
1340
1.73
2.22
4.2
3.0
4.40
4.54
mmol/l
1.36
142
1288
61
437
1.59
2.20
2.0
2.1
2.39
2.30
mg/l
0.17
55
377
28
162
1.86
2.17
1.6
1.3
—
—
—
0
0
6
15
4.10
2.05
1.2
1.0
—
—
—
0
0
5
11
4.64
1.95
1.0
1.0
—
—
—
0
0
5
11
4.64
1.95
1.4
1.0
120.80
109.45
%
—
5
11
27
161
1.79
1.91
1.1
1.0
—
—
—
0
0
8
28
2.94
1.88
4.4
1.5
23.61
23.50
mmol/l
—
8
28
15
74
2.12
1.80
1.9
1.5
—
—
—
0
0
140
1235
1.54
1.76
3.7
2.6
1.22
1.12
mmol/l
1.14
132
1178
70
540
1.48
1.74
3.2
2.6
0.00
0.01
estimate
0.50
29
182
43
300
1.56
1.70
2.7
2.6
27094.08
5036.12
u/l
—
10
133
10
206
0.46
1.65
2.0
1.8
—
—
—
0
0
6
20
3.06
1.59
1.3
1.1
—
—
—
0
0
6
20
3.06
1.59
1.3
1.1
—
—
—
0
0
48
349
1.51
1.58
2.0
2.2
—
—
—
0
0
46
333
1.51
1.54
1.8
2.0
1.03
0.95
mg/l
0.10
33
228
23
140
1.73
1.54
1.7
1.3
45.68
375.16
u/ml
1.26
23
131
15
80
1.95
1.49
1.5
1.2
—
—
—
0
0
39
277
1.52
1.43
1.2
1.3
10.45
16.53
iu/ml
—
6
60
10
46
2.24
1.42
1.0
1.2
—
—
—
0
0
15
83
1.88
1.36
2.9
2.9
0.98
0.75
mmol/l
—
10
60
56
434
1.42
1.32
1.7
1.6
—
—
—
0
0
89
746
1.37
1.31
2.5
1.9
—
—
—
0
0
16
257
0.59
1.22
1.4
1.5
2.68
3.33
ratio
1.25
11
178
10
50
2.06
1.19
8.6
1.8
—
—
—
0
0
14
80
1.81
1.16
1.6
1.3
—
—
—
0
0
11
58
1.95
1.14
1.7
2.1
90.83
92.00
ml/min/173m2
—
6
20
14
227
0.59
1.11
1.6
1.7
—
—
—
0
0
13
77
1.74
0.98
1.8
1.4
—
—
—
0
0
0
32
0.00
0.96
0.0
1.7
—
—
—
0
0
11
179
0.59
0.90
1.5
1.6
51.13
54.84
ug/l
0.12
11
179
22
304
0.69
0.87
1.4
1.5
—
—
—
0
0
30
225
1.40
0.85
1.6
2.4
341.08
309.39
umol/l
0.84
25
210
86
754
1.26
0.81
2.7
3.0
—
—
estimate
—
0
0
0
26
0.00
0.79
0.0
5.0
—
8.43
—
0
26
10
59
1.73
0.77
1.3
1.5
498.00
345.35
mu/l
—
5
51
25
186
1.40
0.75
1.6
2.3
13.20
386.21
ng/l
—
5
68
15
101
1.53
0.72
4.8
2.2
—
—
—
0
0
113
1037
1.23
0.66
3.5
3.3
66.69
53.82
ug/l
0.53
108
999
15
105
1.47
0.62
1.6
1.6
—
—
—
0
0
11
72
1.56
0.60
1.6
1.7
—
—
—
0
0
51
435
1.24
0.60
2.6
1.9
—
—
—
0
0
5
88
0.56
0.57
1.4
1.1
0.60
3.26
u/ml
—
5
52
33
269
1.28
0.56
1.2
1.3
1.68
6.94
u/ml
1.42
14
113
57
498
1.21
0.53
2.0
1.7
1.54
1.26
mmol/l
1.29
48
448
16
119
1.38
0.50
1.6
3.1
111.00
491.27
ng/l
—
9
89
58
514
1.19
0.46
3.1
2.1
—
—
—
0
0
5
32
1.58
0.42
1.0
1.1
—
—
—
0
0
0
15
0.00
0.41
0.0
1.1
—
108.00
—
0
8
0
16
0.00
0.41
0.0
1.3
—
—
—
0
0
0
17
0.00
0.41
0.0
2.0
—
148.67
—
0
12
152
1564
0.85
0.33
4.8
4.2
—
—
—
0
0
12
93
1.31
0.30
1.3
1.3
4.63
3.87
mg/l
0.21
12
56
24
206
1.19
0.28
1.2
1.3
361.27
108.57
u/ml
—
7
81
5
74
0.67
0.26
1.0
1.1
—
15.10
—
0
13
6
83
0.71
0.24
1.2
1.0
1.50
1.52
g/l
—
6
83
6
84
0.70
0.24
1.2
1.1
0.83
0.84
g/l
—
6
84
5
38
1.32
0.23
1.0
1.1
—
—
—
0
0
10
79
1.28
0.23
1.2
2.8
100.00
99.38
%
—
10
79
0
11
0.00
0.21
0.0
2.5
—
115.00
—
0
11
0
11
0.00
0.21
0.0
1.2
—
194.96
—
0
11
0
10
0.00
0.21
0.0
1.1
—
—
—
0
0
0
10
0.00
0.21
0.0
1.1
—
1.46
—
0
10
(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
0
13
0.00
0.21
0.0
1.0
—
—
—
0
0
(3011547) Coagulation factor VII activity actual/normal in Platelet poor plasma by Coagulation assay
0
14
0.00
0.20
0.0
1.1
—
126.86
—
0
14
0
14
0.00
0.20
0.0
1.4
—
—
—
0
0
19
209
0.90
0.12
1.6
1.5
—
—
—
0
0
6
54
1.11
0.09
3.5
1.7
—
—
—
0
0
20
213
0.93
0.06
1.6
1.5
1.22
1.15
ratio
0.08
13
138
20
213
0.93
0.06
1.6
1.5
1.24
1.16
ratio
0.11
13
138
20
213
0.93
0.06
1.6
1.5
0.87
0.94
ratio
0.76
13
138
12
127
0.94
0.01
1.3
1.2
—
—
—
0
0
6
67
0.89
0.00
1.2
1.3
—
—
—
0
0
5
49
1.02
0.00
1.2
1.7
—
—
—
0
0
0
8
0.00
0.00
0.0
1.0
—
787.13
—
0
8
0
6
0.00
-0.00
0.0
1.0
—
4.45
—
0
6
5
54
0.92
-0.00
2.6
2.1
—
23.95
—
0
15
0
6
0.00
-0.00
0.0
1.5
—
43.17
—
0
6
0
5
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
5
0.00
-0.00
0.0
1.0
—
13.72
—
0
5
0
5
0.00
-0.00
0.0
2.2
—
—
—
0
0
0
5
0.00
-0.00
0.0
1.4
—
9.30
—
0
5
0
7
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
5
0.00
-0.00
0.0
2.4
—
—
—
0
0
0
5
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
6
0.00
-0.00
0.0
3.5
—
—
—
0
0
0
5
0.00
-0.00
0.0
2.4
—
—
—
0
0
0
6
0.00
-0.00
0.0
1.0
—
58.35
—
0
6
0
7
0.00
-0.00
0.0
2.7
—
—
—
0
0
Mortality – FinRegistry
↥This endpoint is excluded from FinRegistry analyses (omitted endpoint).
Relationships between endpoints
↥Index endpoint: Z21_OTHER_PROBL_RELATED_UPBRI – Other problems related to upbringing
GWS hits: -
This endpoint is excluded from FinRegistry analyses (omitted endpoint).